Profile data is unavailable for this security.
About the company
Semler Scientific, Inc. develops, manufactures, and markets products and services that assist in evaluating and treating chronic diseases. The Company provides technology solutions to healthcare providers. The Company's flagship product, QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient’s vascular condition, including assessments of patients who have vascular disease. QuantaFlo features a sensor clamp that is placed on the toe or finger. Infrared light emitted from the clamp on the dorsal surface of the digit is scattered and reflected by the red blood cells coursing through the area of illumination. Returning light is sensed by the sensor. A blood flow waveform is instantaneously constructed by its proprietary software algorithm. Its customers for QuantaFlo include insurance plans, physician groups, risk assessment groups, hospitals and retailers.
- Revenue in USD (TTM)61.74m
- Net income in USD15.82m
- Incorporated2013
- Employees92.00
- LocationSemler Scientific Inc2340-2348 Walsh Avenue, Suite 2344SANTA CLARA 95051United StatesUSA
- Phone+1 (408) 627-4557
- Fax+1 (302) 636-5454
- Websitehttps://www.semlerscientific.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EUDA Health Holdings Ltd | 3.71m | -8.44m | 127.86m | 106.00 | -- | -- | -- | 34.50 | -0.3685 | -0.4384 | 0.1707 | -0.3045 | 0.2752 | -- | 3.55 | 34,966.61 | -62.62 | -- | -- | -- | 22.72 | -- | -227.57 | -- | -- | -1.49 | -- | -- | -1.54 | -- | 66.17 | -- | -- | -- |
| 908 Devices Inc. | 52.69m | -37.99m | 127.88m | 230.00 | -- | 0.8173 | -- | 2.43 | -1.15 | -1.15 | 1.60 | 4.52 | 0.2511 | 1.54 | 4.95 | 229,069.60 | -18.11 | -14.16 | -20.12 | -15.35 | 52.32 | 53.02 | -72.10 | -64.25 | 4.23 | -- | 0.00 | -- | 7.21 | 17.89 | -8.45 | -- | 22.98 | -- |
| InfuSystem Holdings Inc | 129.37m | 366.00k | 134.29m | 499.00 | 402.30 | 2.51 | 10.72 | 1.04 | 0.0157 | 0.0157 | 5.99 | 2.51 | 1.22 | 10.38 | 6.44 | 259,264.50 | 0.3465 | 4.60 | 0.401 | 5.69 | 49.68 | 56.43 | 0.2829 | 4.07 | 1.64 | 1.97 | 0.3898 | 0.00 | 14.44 | 13.38 | 4,744.44 | -- | 6.01 | -- |
| Akoya Biosciences Inc | 93.22m | -60.35m | 140.58m | 330.00 | -- | 6.31 | -- | 1.51 | -1.22 | -1.22 | 1.89 | 0.4498 | 0.5605 | 1.93 | 6.34 | 282,472.70 | -36.29 | -- | -45.98 | -- | 57.57 | -- | -64.74 | -- | 1.98 | -8.00 | 0.7755 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
| Acme United Corp | 192.71m | 19.45m | 154.34m | 645.00 | 8.40 | 1.48 | 6.17 | 0.8009 | 4.97 | 4.97 | 48.59 | 28.13 | 1.15 | 2.07 | 4.83 | 298,770.50 | 11.60 | 7.09 | 13.79 | 8.29 | 39.40 | 35.72 | 10.09 | 5.50 | 1.77 | 6.60 | 0.2621 | 18.81 | -1.27 | 6.88 | 486.31 | 31.08 | 9.02 | 4.84 |
| Stereotaxis Inc | 23.75m | -22.08m | 165.08m | 122.00 | -- | 14.25 | -- | 6.95 | -0.265 | -0.265 | 0.285 | 0.202 | 0.5632 | 1.14 | 5.04 | 194,639.30 | -49.21 | -25.02 | -71.93 | -34.12 | 59.28 | 67.57 | -87.38 | -41.90 | 1.53 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
| Semler Scientific Inc | 61.74m | 15.82m | 173.34m | 92.00 | 12.20 | 2.21 | 10.51 | 2.81 | 2.03 | 2.03 | 7.93 | 11.22 | 0.7706 | 16.26 | 9.15 | 671,097.80 | 19.74 | 38.83 | 22.00 | 44.41 | 88.67 | 90.22 | 25.62 | 32.58 | 3.66 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
| Electromed Inc | 54.72m | 5.15m | 175.72m | 174.00 | 35.12 | 3.94 | 29.33 | 3.21 | 0.5791 | 0.5791 | 6.17 | 5.16 | 1.12 | 3.27 | 2.25 | 314,459.80 | 10.51 | 8.64 | 12.51 | 10.09 | 76.26 | 76.26 | 9.41 | 8.06 | 5.27 | -- | 0.00 | 0.00 | 13.83 | 11.82 | 62.67 | 21.06 | -22.23 | -- |
| Trubridge Inc | 336.56m | -52.28m | 182.96m | 3.22k | -- | 1.01 | -- | 0.5436 | -3.68 | -3.68 | 23.64 | 12.12 | 0.7947 | 196.76 | 5.88 | 104,553.30 | -12.66 | 1.25 | -14.34 | 1.41 | 48.70 | 50.40 | -15.93 | 1.56 | 1.76 | 0.6115 | 0.4985 | 45.06 | 3.91 | 3.89 | -387.73 | -- | 88.71 | -- |
| Orchestra Biomed Holdings Inc | 2.08m | -55.58m | 184.96m | 56.00 | -- | 3.97 | -- | 88.97 | -1.57 | -1.57 | 0.0586 | 1.23 | 0.021 | 1.34 | 16.57 | 37,125.00 | -56.06 | -- | -64.66 | -- | 92.02 | -- | -2,673.26 | -- | 4.58 | -- | 0.00 | -- | -21.88 | -- | -37.91 | -- | -- | -- |
| CVRx Inc | 44.39m | -54.39m | 189.32m | 200.00 | -- | 3.42 | -- | 4.26 | -2.57 | -2.57 | 2.10 | 2.54 | 0.4209 | 0.6253 | 5.79 | 221,965.00 | -51.56 | -- | -56.39 | -- | 84.40 | -- | -122.52 | -- | 8.85 | -18.48 | 0.3467 | -- | 74.89 | -- | 0.5528 | -- | -- | -- |
| Accuray Inc | 446.55m | -15.55m | 189.56m | 1.02k | -- | 4.20 | -- | 0.4245 | -0.1596 | -0.1596 | 4.53 | 0.4543 | 0.9423 | 2.14 | 5.36 | -- | -3.28 | -1.37 | -5.61 | -2.33 | 32.05 | 36.42 | -3.48 | -1.55 | 0.947 | 0.3757 | 0.7925 | -- | -0.2355 | 1.29 | -67.51 | -- | -- | -- |
| Neuropace Inc | 71.82m | -29.90m | 199.12m | 171.00 | -- | 20.10 | -- | 2.77 | -1.09 | -1.09 | 2.61 | 0.3392 | 0.7305 | 1.74 | 6.49 | 419,994.20 | -30.41 | -- | -34.66 | -- | 74.15 | -- | -41.63 | -- | 5.47 | -4.37 | 0.8565 | -- | 43.72 | -- | 30.00 | -- | -- | -- |
| Nevro Corp | 426.10m | -77.44m | 216.99m | 1.22k | -- | 0.7895 | -- | 0.5092 | -2.12 | -2.12 | 11.69 | 7.37 | 0.7266 | 1.11 | 5.93 | 350,697.90 | -13.21 | -13.64 | -15.59 | -16.68 | 68.06 | 68.54 | -18.18 | -20.67 | 3.53 | -28.95 | 0.4433 | -- | 4.63 | 1.88 | -3,172.74 | -- | 0.9012 | -- |
| Senseonics Holdings Inc | 24.04m | -80.46m | 219.64m | 132.00 | -- | 379.79 | -- | 9.14 | -0.1323 | -0.1323 | 0.0395 | 0.0714 | 0.1815 | 2.58 | 5.99 | 182,113.60 | -60.74 | -73.65 | -74.52 | -106.97 | 12.04 | -40.41 | -334.69 | -649.86 | 2.89 | -10.93 | 0.5802 | -- | 36.62 | 3.43 | -142.49 | -- | -18.76 | -- |
Data as of Sep 19 2024. Currency figures normalised to Semler Scientific Inc's reporting currency: US Dollar USD
30.41%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Cerity Partners LLCas of 30 Jun 2024 | 702.60k | 10.05% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 324.05k | 4.63% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 303.97k | 4.35% |
| AQR Capital Management LLCas of 30 Jun 2024 | 140.50k | 2.01% |
| Geode Capital Management LLCas of 30 Jun 2024 | 123.00k | 1.76% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 117.50k | 1.68% |
| Acadian Asset Management LLCas of 30 Jun 2024 | 116.22k | 1.66% |
| Dimensional Fund Advisors LPas of 30 Jun 2024 | 110.29k | 1.58% |
| Jacobs Levy Equity Management, Inc.as of 30 Jun 2024 | 105.37k | 1.51% |
| LPL Financial LLCas of 30 Jun 2024 | 82.78k | 1.18% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
